Muken Ross 4
Research Summary
AI-generated summary
SOPHiA GENETICS (SOPH) President Muken Ross Sells 422 Shares
What Happened Muken Ross, President of SOPHiA GENETICS SA (SOPH), sold 422 shares on June 22, 2026, in an open‑market transaction. The reported weighted average sale price was $5.38 per share, for proceeds of approximately $2,270. This sale was to satisfy tax withholding obligations related to RSUs that vested on June 18, 2026.
Key Details
- Transaction date: 2026-06-22 (filed 2026-06-23)
- Action: Sale (S) of 422 shares; weighted average price $5.38; total ≈ $2,270
- Price range: shares sold in multiple trades at $5.33–$5.48 (Reporting Person can provide per‑trade breakdown on request) (F2)
- Reason/footnote: Shares sold in open market to satisfy tax withholding on RSU vesting; sales executed under a pre‑established Rule 10b5‑1(c) plan (non‑discretionary) (F1)
- Shares owned after transaction: Not reported in the provided Form 4 data
- Timeliness: Filed the next day (no late filing flag)
Context This was a routine, tax‑related sale under a 10b5‑1 plan rather than a discretionary divestiture. Such transactions commonly occur when restricted stock units vest and do not necessarily signal a change in the insider’s view of the company.